CORRECTION: On Friday, Unicycive Therapeutics Reported Q4 EPS Of $(0.22), Which Missed $(0.17) Estimate
CORRECTION: On Friday, Unicycive Therapeutics Reported Q4 EPS Of $(0.22), Which Missed $(0.17) Estimate
更正：週五，Unicycive Therapeutics公佈的第四季度每股收益爲0.22美元（0.22美元），未達到預期（0.17美元）
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 56.86 percent increase over losses of $(0.51) per share from the same period last year.
Unicycive Therapeutics（納斯達克股票代碼：UNCY）公佈的季度虧損爲每股0.22美元，比分析師普遍預期的0.17美元（0.17美元）低29.41％。與去年同期每股虧損0.51美元（0.51美元）相比，增長了56.86％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。